Carbaglu 200 mg, Tabletten zur Herstellung einer Suspension zum Einnehmen - 60 Swissmedic Key 67376002 Registration Holder Recordati AG Name Carbaglu 200 mg, Tabletten zur Herstellung einer Suspension zum Einnehmen Date of registration 28.07.2020 Introduction of Sequence 28.07.2020 ATC-Classification Carglumic Acid (A16AA05) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size 60 Index Therapeuticus (Swissmedic) 07.99. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680673760024 Medication Code Synthetika Pharmacode Disponibility
Composition acidum carglumicum 200 mg, cellulosum microcristallinum, natrii laurilsulfas, hypromellosum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, pro compresso corresp., natrium 1.66 mg. Packungsbestandteile Galenic Form Inactive agents Hypromellosum Silica Colloidalis Anhydrica
Source Data was imported : 04.12.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
